A detailed history of First Foundation Advisors transactions in Medtronic PLC stock. As of the latest transaction made, First Foundation Advisors holds 7,611 shares of MDT stock, worth $616,719. This represents 0.03% of its overall portfolio holdings.

Number of Shares
7,611
Previous 11,078 31.3%
Holding current value
$616,719
Previous $871,000 21.35%
% of portfolio
0.03%
Previous 0.03%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$76.84 - $91.03 $266,404 - $315,601
-3,467 Reduced 31.3%
7,611 $685,000
Q2 2024

Aug 06, 2024

BUY
$78.71 - $87.02 $20,622 - $22,799
262 Added 2.42%
11,078 $871,000
Q1 2024

May 09, 2024

SELL
$82.84 - $88.09 $47,633 - $50,651
-575 Reduced 5.05%
10,816 $942,000
Q4 2023

Feb 14, 2024

SELL
$69.43 - $83.43 $166,145 - $199,647
-2,393 Reduced 17.36%
11,391 $938,000
Q3 2023

Nov 15, 2023

SELL
$78.22 - $90.4 $176,777 - $204,304
-2,260 Reduced 14.09%
13,784 $1.08 Million
Q2 2023

Aug 14, 2023

SELL
$79.47 - $91.38 $1.53 Million - $1.76 Million
-19,247 Reduced 54.54%
16,044 $1.41 Million
Q1 2023

May 12, 2023

SELL
$76.72 - $87.58 $1.17 Million - $1.34 Million
-15,287 Reduced 30.22%
35,291 $2.85 Million
Q4 2022

Feb 14, 2023

SELL
$76.18 - $87.74 $1.81 Million - $2.08 Million
-23,732 Reduced 31.94%
50,578 $3.93 Million
Q3 2022

Nov 10, 2022

SELL
$80.75 - $95.31 $17.1 Million - $20.2 Million
-211,616 Reduced 74.01%
74,310 $6 Million
Q2 2022

Aug 12, 2022

SELL
$87.4 - $113.09 $4.34 Million - $5.62 Million
-49,682 Reduced 14.8%
285,926 $25.7 Million
Q1 2022

May 05, 2022

SELL
$100.58 - $112.38 $2.48 Million - $2.78 Million
-24,700 Reduced 6.86%
335,608 $37.2 Million
Q4 2021

Feb 14, 2022

BUY
$99.53 - $127.75 $7.33 Million - $9.41 Million
73,627 Added 25.68%
360,308 $37.3 Million
Q3 2021

Nov 15, 2021

BUY
$122.75 - $135.17 $231,874 - $255,336
1,889 Added 0.66%
286,681 $35.9 Million
Q2 2021

Aug 13, 2021

SELL
$118.19 - $131.5 $249,971 - $278,122
-2,115 Reduced 0.74%
284,792 $35.4 Million
Q1 2021

May 18, 2021

BUY
$111.18 - $119.74 $9,005 - $9,698
81 Added 0.03%
286,907 $33.9 Million
Q4 2020

Feb 16, 2021

SELL
$100.57 - $117.14 $28.7 Million - $33.4 Million
-284,981 Closed
0 $0
Q3 2020

Nov 12, 2020

BUY
$90.13 - $108.78 $867,050 - $1.05 Million
9,620 Added 3.49%
284,981 $29.6 Million
Q2 2020

Aug 14, 2020

SELL
$84.11 - $103.33 $358,308 - $440,185
-4,260 Reduced 1.52%
275,361 $25.3 Million
Q1 2020

May 11, 2020

SELL
$72.92 - $121.3 $800,953 - $1.33 Million
-10,984 Reduced 3.78%
279,621 $25.2 Million
Q4 2019

Feb 11, 2020

BUY
$104.49 - $114.54 $164,362 - $180,171
1,573 Added 0.54%
290,605 $33 Million
Q3 2019

Nov 12, 2019

SELL
$98.02 - $111.18 $329,445 - $373,675
-3,361 Reduced 1.15%
289,032 $31.4 Million
Q2 2019

Aug 14, 2019

SELL
$84.15 - $99.38 $435,139 - $513,893
-5,171 Reduced 1.74%
292,393 $28.5 Million
Q1 2019

May 13, 2019

SELL
$82.45 - $93.79 $1.22 Million - $1.38 Million
-14,755 Reduced 4.72%
297,564 $27.1 Million
Q4 2018

Feb 14, 2019

SELL
$85.8 - $99.49 $600 - $696
-7 Reduced -0.0%
312,319 $28.4 Million
Q3 2018

Nov 13, 2018

SELL
$85.91 - $99.17 $765,372 - $883,505
-8,909 Reduced 2.77%
312,326 $30.7 Million
Q2 2018

Aug 14, 2018

SELL
$77.48 - $87.83 $3.53 Million - $4.01 Million
-45,600 Reduced 12.43%
321,235 $27.5 Million
Q1 2018

May 15, 2018

BUY
$76.55 - $87.26 $144,296 - $164,485
1,885 Added 0.52%
366,835 $29.4 Million
Q4 2017

Feb 14, 2018

BUY
$76.93 - $83.5 $1.09 Million - $1.18 Million
14,178 Added 4.04%
364,950 $29.5 Million
Q3 2017

Nov 14, 2017

BUY
$77.71 - $84.6 $1.05 Million - $1.15 Million
13,576 Added 4.03%
350,772 $27.3 Million
Q2 2017

Aug 14, 2017

BUY
N/A
337,196
337,196 $29.9 Million

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $108B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track First Foundation Advisors Portfolio

Follow First Foundation Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Foundation Advisors, based on Form 13F filings with the SEC.

News

Stay updated on First Foundation Advisors with notifications on news.